A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months
Clinical trial NCT07036159 · RECRUITING
Trial details
- NCT number
- NCT07036159
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-06
- Primary completion
- 2027-04-23
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.